Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Sarah Gerlo
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
29
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Administrative supervisor
26 January 2022 → 21 September 2025
Chronische HIV infectie: waar gaat het fout met de innate lymfoiede cellen (ILCs)?
Doctoral researcher: Loic Schrooyen
19 November 2018 → 22 September 2019
Doctoral project Kaat Leroy
Doctoral researcher: Kaat Leroy
18 November 2024 → 21 September 2025
Generation of HIV Env-targeting nanobodies for application in innovative immunotherapy strategies
Doctoral researcher: Maurits Ranson
As
PhD Supervisor
18 December 2018 → 13 January 2025
Beyond Diagnosis: Early Antiretroviral Treatment and HIV Immunopathogenesis in a Belgian Acute HIV Infection Cohort
Doctoral researcher: Jozefien De Clercq
29 December 2022 → 22 September 2024
Development of nanobody based stratigies for an HIV cure
Doctoral researcher: Justine Meirlevede
08 July 2013 → 24 September 2017
Doctoral project Elke Depreester
Doctoral researcher: Elke Depreester
As
Promotor
01 February 2011 → 31 January 2021
BOF-ZAP professorship in molecular biology
Fellows: Sarah Gerlo
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2019
Development of IL-1β AcTakines: new adjuvants in vaccination
Fellows: Bram Van Den Eeckhout
Funding: Research Foundation - Flanders (FWO)
01 November 2024 → 31 October 2028
Generation of HIV Env-targeting nanobodies for application in innovative immunotherapy strategies.
Fellow: Maurits Ranson
Funding: Research Foundation - Flanders (FWO)
01 January 2024 → 31 December 2025
Generation of HIV Env-targeting nanobodies for application in innovative immunotherapy strategies
Funding: Regional and community funding: Special Research Fund
01 January 2018 → 31 December 2021
Investigation into the efficacy of IL-1b AcTaleukins as adjuvant for cancer immunotherapy.
Funding: Research Foundation - Flanders (FWO)
01 November 2024 → 31 October 2028
Unraveling host and viral factors underlying HIV latency in the gut
Fellow: Juliette Dewatines
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 January 2014 → 31 December 2019
AcTakines: old monkeys new tricks
Funding: Research Foundation - Flanders (FWO)
01 December 2020 → 30 November 2023
Automated system for high-pure extraction of RNA and DNA from samples of limited quantity.
Funding: Regional and community funding: Special Research Fund
22 May 2020 → 31 May 2021
COVID-Trace: from tracking virus-host interactions at the single-cell level to tracing cellular markers for clinical patient stratification.
Funding: Research Foundation - Flanders (FWO)
01 January 2024 → 31 December 2027
Generation of a dynamic spatial map of the cellular landscape of HIV-infected gut and its application in unraveling the role of tissue-resident T cells in HIV
Funding: Research Foundation - Flanders (FWO)
15 December 2022 → 14 December 2024
HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVEL
Funding: Regional and community funding: Special Research Fund
01 November 2023 → 31 October 2027
HIV Nanoheroes: novel CRISPR/Cas9-based CD4+ cell-specific HHV-7 vectors to cure HIV
Fellow: Rianne Verbeek
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 October 2026
How do ILCs go wrong: unravelling the mechanisms of ILC depletion and functions in HIV infection
Fellow: Loic Schrooyen
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2015
Investigation into mediators of central leptin sensitization upon acute exercise
Fellow: Sarah Gerlo
Funding: Research Foundation - Flanders (FWO)
01 January 2018 → 31 December 2021
Investigation into the efficacy of IL-1b AcTaleukins as adjuvant for cancer immunotherapy.
Funding: Research Foundation - Flanders (FWO)
01 January 2019 → 31 December 2022
Preclinical evaluation of chemogenetics as new treatment for drug-resistant epilepsy
Fellow: Jana Desloovere
Funding: Research Foundation - Flanders (FWO)
01 November 2019 → 30 September 2024
Preclinical evaluation of Vagus Nerve Stimulation as a therapeutic option in Multiple Sclerosis.
Fellow: Helen Bachmann
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 September 2014
Study of crosstalk between GPCR-mediated signals and the NF-kappaB signal transduction cascade.
Fellows: Krzysztof Kolmus
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
15 November 2019 → 13 January 2024
Use of bispecific AcTakines to boost innate and adaptive immune responses after acute HIV-1 infection
Fellow: Jozefien De Clercq
Funding: Regional and community funding: Special Research Fund
As
Fellow
01 February 2011 → 31 January 2021
BOF-ZAP professorship in molecular biology
Fellows: Sarah Gerlo
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2015
Investigation into mediators of central leptin sensitization upon acute exercise
Fellow: Sarah Gerlo
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2013
Study of crosstalk between beta2-adrenergic signals and the NF-κB cascade. Relevance for neuroinflammation/ neurodegeneration.
Fellows: Sarah Gerlo
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
As
Researcher
15 April 2020 → 14 April 2021
Covid-Track: applying quantitative virology and single-cell genomics to unravel the virus-host interactions leading to severe immunopathologies in COVID-19 patients
Funding: Regional and community funding: Special Research Fund